A retrospective look at how clinical research trials were prioritized in New York City in the wake of the COVID-19 pandemic provides insights for future clinical research efforts.
Roy M. Gulick, Magdalena E. Sobieszczyk, Donald W. Landry, Anthony N. Hollenberg
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) focuses on many diseases that place disparate burdens on minority groups and the poor, such as obesity, diabetes, and kidney disease. Here, we highlight the NIDDK's commitment to combating health disparities through basic, translational, and clinical research.
B. Tibor Roberts, Griffin P. Rodgers
Yasmin L. Hurd
Broadly activating innate immunity, which has been achieved via unrelated vaccines or Type-I INF-like factors, may effectively treat or prevent COVID-19 and future coronavirus diseases.
Leonard Angka, Marisa Market, Michele Ardolino, Rebecca C. Auer
Lucy Y. Ghoda, Steven T. Rosen, Larry W. Kwak
David T. Ting, Julius J.S. Knowles
Norman E. Sharpless
In COVID-19, complement activation may contribute to hemostatic activation leading to pathological features such as microvascular injury and coagulopathy.
Wen-Chao Song, Garret A. FitzGerald
Mark Donowitz, Jerrold R. Turner, Alan S. Verkman, Nicholas Constantine Zachos
Laura E. Crotty Alexander, Amy L. Bellinghausen, Michelle N. Eakin
No posts were found with this tag.